D-dimer Testing

Global D-dimer Testing Market to Reach US$2.0 Billion by 2030

The global market for D-dimer Testing estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$425.9 Million While China is Forecast to Grow at 3.8% CAGR

The D-dimer Testing market in the U.S. is estimated at US$425.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$317.9 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global D-dimer Testing Market - Key Trends & Drivers Summarized

Why Is D-dimer Testing Crucial for Modern Healthcare Diagnostics?

D-dimer testing is an essential diagnostic tool used to detect blood clotting disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This test measures the presence of D-dimer, a protein fragment that forms when a blood clot dissolves, indicating abnormal clotting activity within the body. It plays a critical role in the emergency and clinical settings, as it helps rule out serious conditions quickly and effectively. Given the rising incidence of cardiovascular diseases and venous thromboembolism (VTE), D-dimer testing has become increasingly vital in healthcare, ensuring timely intervention and improved patient outcomes. As the demand for efficient and accurate diagnostic solutions grows, the use of D-dimer tests is expanding across hospitals, diagnostic centers, and laboratories worldwide.

How Are Technological Innovations Enhancing D-dimer Testing?

Technological advancements are transforming the D-dimer testing market, improving the accuracy, speed, and convenience of diagnostic processes. Innovations in point-of-care (POC) testing devices now allow for rapid D-dimer analysis in emergency settings, providing results in minutes and enabling quicker clinical decisions. Automated and high-sensitivity assay systems have also been developed, enhancing the precision of D-dimer measurements and minimizing false positives. Integration of D-dimer testing into multiplex testing platforms that combine multiple biomarkers is further enhancing diagnostic capabilities, particularly for detecting and managing complex conditions like COVID-19-related coagulopathies. These innovations are not only increasing the effectiveness of D-dimer testing but are also expanding its adoption across various healthcare settings, contributing to market growth.

What Trends Are Driving the Adoption of D-dimer Testing in Healthcare Facilities?

The increased focus on early diagnosis and preventive care is driving the adoption of D-dimer testing in healthcare facilities. With cardiovascular diseases remaining a leading cause of mortality globally, healthcare providers are increasingly utilizing D-dimer tests as a quick and reliable method to screen for thrombotic disorders. The demand for POC diagnostic solutions is also boosting market growth, as these tests enable healthcare professionals to conduct assessments in emergency rooms, intensive care units, and remote locations. Furthermore, the ongoing impact of the COVID-19 pandemic has highlighted the importance of coagulation testing, leading to a surge in demand for D-dimer tests to monitor and manage coagulopathies associated with the virus. This trend is expected to continue as healthcare systems prioritize enhanced diagnostic capabilities.

What Factors Are Driving Growth in the D-dimer Testing Market?

The growth in the D-dimer testing market is driven by several factors, including the rising prevalence of cardiovascular and thrombotic diseases, advancements in POC testing technology, and the expanding need for quick diagnostics in emergency care settings. The global increase in chronic conditions such as diabetes and obesity, which are associated with higher risks of blood clots, is further boosting the demand for D-dimer tests. Technological improvements, such as automated and high-sensitivity assays, are enhancing test accuracy and efficiency, encouraging healthcare facilities to integrate these systems into their diagnostic protocols. Additionally, the impact of the COVID-19 pandemic has elevated the importance of coagulation testing, driving investments in D-dimer diagnostic solutions. The combination of these factors is fueling the expansion of the D-dimer testing market across hospitals, laboratories, and POC settings.

SCOPE OF STUDY:

The report analyzes the D-dimer Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Reagents & Consumables, Analyzers); Test Type (Clinical Laboratory Tests, Point-of-Care Tests); Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications); End-Use (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

• Abbott Laboratories, Inc.
• Alere, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio/Data Corporation
• Corgenix
• F. Hoffmann-La Roche AG
• Helena Biosciences Europe
• Siemens Healthcare GmbH
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Trinity Biotech PLC

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.